Revascularization in patients with diabetes: PCI or CABG or none at all

Area of Science:

• Cardiology
• Diabetology
• Interventional Cardiology

Background:

• Diabetic patients face high rates of coronary artery disease (CAD), acute coronary syndromes, and mortality.
• Coronary artery bypass grafting (CABG) has long been effective for extensive CAD.
• Percutaneous coronary intervention (PCI) with drug-eluting stents improves quality of life in diabetic patients with less extensive CAD.

Purpose of the Study:

• To compare the efficacy of CABG versus PCI in diabetic patients with CAD.
• To evaluate the role of revascularization strategies in diabetic patients with varying degrees of CAD extent and surgical risk.

Main Methods:

• Review of historical and recent clinical data comparing CABG and PCI in diabetic patients.
• Analysis of outcomes based on CAD extent (three-vessel vs. less extensive) and surgical risk.
• Consideration of novel treatment strategies including second-generation drug-eluting stents, fractional flow reserve guidance, and hybrid revascularization.

Main Results:

• CABG demonstrates superior mortality benefits over PCI in diabetic patients with three-vessel CAD and low surgical risk.
• PCI with drug-eluting stents improves angina and quality of life in diabetic patients with less extensive CAD.
• Optimal revascularization strategies for diabetic patients with less extensive CAD and/or higher surgical risk remain under investigation.

Conclusions:

• CABG remains a preferred strategy for high-risk diabetic patients with extensive CAD.
• Emerging PCI technologies and hybrid approaches may offer improved outcomes for select diabetic patients.
• Further research is needed to fully elucidate the comparative effectiveness of different revascularization strategies in diabetic patients with complex CAD profiles.